Press Releases

February 28, 2023
MONTREAL and CHARLOTTE, N.C. , Feb. 28, 2023 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that members of its management team will present at the
Displaying 11 - 13 of 13
Print Page
RSS Feeds
Email Alerts
Investor Contact